Tvardi Therapeutics, Inc TVRD

NAS: TVRD | ISIN: US1407553072 16/12/2025

4,200 USD (-0,47%)

(-0,47%) 16/12/2025

Grafiek Tvardi Therapeutics, Inc

Grafiek Tvardi Therapeutics, Inc

1 dag1d -0,47%
1 week1w -7,28%
1 maand1m 4,22%
3 maanden3m -89,24%
6 maanden6m -83,25%
1 jaar1j -76,98%
5 jaar5j -76,98%

Tvardi Therapeutics, Inc in het nieuws

Toon enkel gratis nieuws

17 december 2025 · TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

11 december 2025 · TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

4 december 2025 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

30 november 2025 · TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

21 november 2025 · TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

14 november 2025 · SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi · Persbericht

3 november 2025 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

28 oktober 2025 · TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

23 oktober 2025 · Faruqi & Faruqi Reminds Tvardi Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 - TVRD · Persbericht

15 oktober 2025 · TVRD SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe